IM Cannabis (IMCC) Other Accumulated Expenses (2023 - 2026)

IM Cannabis' Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 37.33% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 37.33% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, up 19.22% from the prior year.
• Other Accumulated Expenses declined to $3.8 million in Q1 2026 per IMCC's latest filing, from $4.4 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $10.1 million in Q3 2025 and bottomed at $3.6 million in Q4 2024.
• The 4-year median for Other Accumulated Expenses is $4.6 million (2023), against an average of $5.5 million.
• Across the five-year window, Other Accumulated Expenses increased 21.65% in 2025 and tumbled 37.33% in 2026, its largest moves.
• Year by year, Other Accumulated Expenses stood at $4.6 million in 2023, then dropped by 21.62% to $3.6 million in 2024, then advanced by 21.65% to $4.4 million in 2025, then retreated by 12.98% to $3.8 million in 2026.
• Per Business Quant, the three latest IMCC Other Accumulated Expenses figures stand at $3.8 million (Q1 2026), $4.4 million (Q4 2025), and $10.1 million (Q3 2025).